Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
For children who are not seriously ill or injured, other solutions can be considered, such as the 811 line or walk-in clinics,' one medical director said.
The pythons can go months — perhaps even longer than a year — without eating. But when they do it is a gourmand’s feast, with the python sometimes consuming a meal equivalent to its entire body weight ...
New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.